Amy Welsh

Chief Commercial Officer, AGILE THERAPEUTICS INC.

Companies

AGILE THERAPEUTICS INCChief Commercial Officer Nov 9, 2022 to Aug 26, 2024¹

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

AGILE THERAPEUTICS INC0 shares²Aug 26, 2024

As of each latest filing. The line shows shares held over time.

Recent filings

Aug 26, 2024Returned to company 3,375 shares at $1.52 of AGILE THERAPEUTICS INC²
Aug 26, 2024Returned to company 10,125 shares at $1.52 of AGILE THERAPEUTICS INC²
Jun 28, 2023Granted 13,500 shares of AGILE THERAPEUTICS INC³

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGARAGILE THERAPEUTICS INC, Chief Commercial Officer
2
SEC EDGARAGILE THERAPEUTICS INC shares after the filing of Aug 26, 2024
3
SEC EDGARForm 4 filed Jun 30, 2023